When Bad Antitrust Costs Lives: The Illumina/GRAIL Tragedy

Alden Abbott April 4, 2023

Truth on the Market View Original Source

• 
  Back
  to Top

Regrettably, but not unexpectedly, the Federal Trade Commission (FTC) yesterday threw out a reasoned decision by its administrative law judge and ordered DNA-sequencing provider Illumina Inc. to divest GRAIL Inc., makers of a multi-cancer early detection (MCED) test.

Read the full piece here.